Exchange Traded Concepts, LLC Amicus Therapeutics, Inc. Call Options Transaction History
Exchange Traded Concepts, LLC
- $4.74 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FOLD
# of Institutions
311Shares Held
283MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$251 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$209 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$208 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$199 Million3.18% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$134 Million0.38% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.41B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...